Genus plc (LON:GNS – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2,112.85 ($28.66) and traded as high as GBX 2,755 ($37.37). Genus shares last traded at GBX 2,615 ($35.47), with a volume of 70,297 shares.
Wall Street Analyst Weigh In
GNS has been the topic of a number of research reports. Shore Capital reiterated a “buy” rating and set a GBX 2,900 price target on shares of Genus in a research report on Thursday, September 4th. Deutsche Bank Aktiengesellschaft raised their target price on Genus from GBX 2,250 to GBX 2,550 and gave the company a “buy” rating in a research report on Tuesday, July 15th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat, Genus has a consensus rating of “Buy” and a consensus target price of GBX 2,725.
Check Out Our Latest Report on Genus
Genus Trading Down 3.5%
Genus (LON:GNS – Get Free Report) last issued its quarterly earnings results on Thursday, September 4th. The company reported GBX 81.80 earnings per share (EPS) for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. On average, analysts predict that Genus plc will post 70.9644323 EPS for the current year.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Articles
- Five stocks we like better than Genus
- The How And Why of Investing in Oil Stocks
- Tesla’s U.S. Market Is At An 8-Year Low… How Bad Could It Get?
- The 3 Best Retail Stocks to Shop for in August
- Congress: The Biggest Trades Impacting Markets Today
- There Are Different Types of Stock To Invest In
- 3 Companies Boosting Buybacks While Others Pull Back
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.